The company aims to develop, optimize, produce, and market biotechnological processes and active ingredients for the prevention, treatment, and diagnosis of human diseases, including age-related diseases. In addition, the company offers consulting services to biotechnology companies, biopharmaceutical companies, and pharmaceutical companies that intend to develop biotechnological processes and active ingredients or invest in, acquire, or divest biotechnological concepts. The company may also participate in other companies of any kind, both domestically and abroad, found such companies, take them over, and merge with them. It may acquire, encumber, and dispose of real estate and intellectual property rights, both domestically and abroad, and establish branches and agencies domestically or abroad by resolution of the management. Furthermore, the company may acquire, manage, and sell securities. The company may also provide financing on its own or another's account and enter into guarantees, sureties, and other security transactions for other group companies. It may grant loans or credits to its direct or indirect shareholders or other group companies, conclude cash pooling agreements with them, and provide securities of any kind for their liabilities to third parties.